On Tuesday, Shares of SouFun Holdings Ltd. (NYSE:SFUN), lost -3.87% to $8.94, despite Technology stocks were higher Tuesday with shares of technology companies in the S&P 500 rising about 0.6% in afternoon trade.
On May 20, SouFun Holdings declared its unaudited financial results for the three months ended March 31, 2015.
First Quarter 2015 Highlights
- Total Revenue raised by 1.8% year-on-year to $123.5 million for the three months ended March 31, 2015. Revenue from e-commerce services raised by 75.2% year-on-year to $51.5 million for the three months ended March 31, 2015.
- Operating income reduced by 84.9% year-on-year to $7.5 million for the three months ended March 31, 2015. Non-GAAP operating income reduced by 84.5% year-on-year to $7.9 million for the three months ended March 31, 2015. A description of the adjustments from GAAP to non-GAAP operating income is set forth below.
- Net income attributable to SouFun’s shareholders reduced by 85.3% year-on-year to $6.1 million for the three months ended March 31, 2015.
- Fully diluted earnings per ADS reduced by 90.0% year-on-year to $0.01 for the three months ended March 31, 2015.
SouFun Holdings Limited operates a real estate Internet portal, and home furnishing and improvement Websites in the People’s Republic of China. The company offers marketing services on its Websites, primarily through advertisements to real estate developers in the marketing phase of new property developments, in addition to to real estate agencies; and suppliers of home furnishing and improvement, and other home-related products and services.
Shares of Boston Scientific Corporation (NYSE:BSX), inclined 1.21% to $17.58, during its last trading session.
On June 4, Boston Scientific Corporation, declared the European launch of the Precision Novi™ Spinal Cord Stimulator (SCS) System at the International Neuromodulation Society in Montreal, Canada. The 16-contact primary cell device has CE Mark for the treatment of chronic pain, and is the smallest high-capacity primary cell device presently accessible. The improved shape of the Precision Novi implant is designed to provide a new level of comfort to patients with pain treated using primary cell therapy. Precision Novi is powered by Illumina 3D™ Software that enables physicians to target pain precisely with point-and-click simplicity.
Chronic pain can have a devastating impact on quality of life for many patients. Spinal cord stimulators alleviate pain by stimulating the nerve fibers in the spinal cord to reduce pain signals. While primary cell (also referred to as non-rechargeable) devices are typically larger due to limitations in technology and battery size, the Precision Novi System represents a noteworthy technology advance, with the smallest high-capacity battery on the market, allowing effective pain relief to be delivered from a much smaller device. The Precision Novi System is also the only primary cell device that couples with a wireless remote , empowering patients with flexibility and control over their pain administration.
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in three segments: Cardiovascular, Rhythm Administration, and MedSurg.
Finally, BlackBerry Limited (NASDAQ:BBRY), ended its last trade with -1.38% loss, and closed at $9.26.
BlackBerry Limited, will hold its Annual and Special Meeting of Shareholders on Tuesday, June 23rd, 2015 at 10am ET in Waterloo, Ontario.
BlackBerry Limited provides wireless communications solutions worldwide. The company offers BlackBerry wireless solutions, which comprise the sale of BlackBerry handheld devices; and the provision of data communication, and compression and security infrastructure services enabling BlackBerry handheld wireless devices to send and receive wireless messages and data.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
